Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of early communicative behavior in mouse models of neurofibromatosis type 1
Susan E. Maloney, Krystal Chandler, Corina Anastasaki, et al.
Autism Research (2017) Vol. 11, Iss. 1, pp. 44-58
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

An update on the central nervous system manifestations of neurofibromatosis type 1
J. Stephen Nix, Jaishri O. Blakeley, Fausto J. Rodríguez
Acta Neuropathologica (2019) Vol. 139, Iss. 4, pp. 625-641
Open Access | Times Cited: 92
ERK/MAPK signaling and autism spectrum disorders
Joseph Vithayathil, Joanna Pucilowska, Gary E. Landreth
Progress in brain research (2018), pp. 63-112
Closed Access | Times Cited: 86
RAS and beyond: the many faces of the neurofibromatosis type 1 protein
Corina Anastasaki, Paola Orozco, David H. Gutmann
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 42
A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation
Jiayang Chen, Mary E. Lambo, Xia Ge, et al.
Neuron (2021) Vol. 109, Iss. 23, pp. 3775-3792.e14
Open Access | Times Cited: 55
Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure
Susan E. Maloney, Shyam K. Akula, Michael A. Rieger, et al.
eNeuro (2018) Vol. 5, Iss. 4, pp. ENEURO.0120-18.2018
Open Access | Times Cited: 35
Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models
Nathan Kopp, Katherine B. McCullough, Susan E. Maloney, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 20, pp. 3443-3465
Open Access | Times Cited: 33
Autism Spectrum Disorder Symptom Profile Across the RASopathies
Marie‐Maude Geoffray, Bruno Falissard, Jonathan Green, et al.
Frontiers in Psychiatry (2021) Vol. 11
Open Access | Times Cited: 21
Extensive characterization of a Williams syndrome murine model shows Gtf2ird1‐mediated rescue of select sensorimotor tasks, but no effect on enhanced social behavior
Kayla R. Nygaard, Susan E. Maloney, Raylynn G. Swift, et al.
Genes Brain & Behavior (2023) Vol. 22, Iss. 4
Open Access | Times Cited: 7
Mice lackingAstn2have ASD-like behaviors and altered cerebellar circuit properties
Michalina Hanzel, Kayla Fernando, Susan E. Maloney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Impact of pathogenic variants of the Ras-Mitogen-activated protein kinase (Ras-MAPK) pathway on major white matter tracts in the human brain
Monica Siqueiros Sanchez, Erpeng Dai, Chloe McGhee, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 2
Reducing filamin A restores cortical synaptic connectivity and early social communication following cellular mosaicism in ASD pathways
Matthew S. Binder, Iris Escobar, Youfen Xu, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 39, pp. e1245232024-e1245232024
Closed Access | Times Cited: 2
Using animal models to evaluate the functional consequences of anesthesia during early neurodevelopment
Susan E. Maloney, Catherine E. Creeley, Richard E. Hartman, et al.
Neurobiology of Learning and Memory (2018) Vol. 165, pp. 106834-106834
Open Access | Times Cited: 21
MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders
Sarah C. Borrie, Ellen Plasschaert, Zsuzsanna Callaerts‐Vegh, et al.
Molecular Autism (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Genetic and Environmental Contributions to Autism Spectrum Disorder Through Mechanistic Target of Rapamycin
Atsushi Sato, Kazutaka Ikeda
Biological Psychiatry Global Open Science (2021) Vol. 2, Iss. 2, pp. 95-105
Open Access | Times Cited: 17
Neurofibromatosis type 1 as a model system to study molecular mechanisms of autism spectrum disorder symptoms
Andrei I. Molosh, Anantha Shekhar
Progress in brain research (2018), pp. 37-62
Closed Access | Times Cited: 18
NF1-cAMP signaling dissociates cell type–specific contributions of striatal medium spiny neurons to reward valuation and motor control
Laurie P. Sutton, Brian S. Muntean, Olga Ostrovskaya, et al.
PLoS Biology (2019) Vol. 17, Iss. 10, pp. e3000477-e3000477
Open Access | Times Cited: 17
Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders
Jessica A. Kaczorowski, Taylor F. Smith, Amanda M. Shrewsbury, et al.
Behavior Genetics (2020) Vol. 50, Iss. 4, pp. 191-202
Open Access | Times Cited: 15
A Targeted, Low-Throughput Compound Screen in aDrosophilaModel of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)
Alex Dyson, Megan Ryan, Shruti Garg, et al.
eNeuro (2023) Vol. 10, Iss. 5, pp. ENEURO.0461-22.2023
Open Access | Times Cited: 5
A new era for myelin research in Neurofibromatosis type 1
Peter de Blank, Akiko Nishiyama, Alejandro López‐Juárez
Glia (2023) Vol. 71, Iss. 12, pp. 2701-2719
Closed Access | Times Cited: 5
Ontogenetic Oxycodone Exposure Affects Early Life Communicative Behaviors, Sensorimotor Reflexes, and Weight Trajectory in Mice
Elena Minakova, Simona Sarafinovska, Marwa O. Mikati, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 15
Open Access | Times Cited: 12
Mice lacking Astn2 have ASD-like behaviors and altered cerebellar circuit properties
Michalina Hanzel, Kayla Fernando, Susan E. Maloney, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 34
Open Access | Times Cited: 1
Neurofibromatosis type 1
Jordan J. Cole, Rosalie E. Ferner, David H. Gutmann
Elsevier eBooks (2024), pp. 231-249
Closed Access | Times Cited: 1
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment
Andrew H. Miller, Mary C. Halloran
Disease Models & Mechanisms (2022) Vol. 15, Iss. 8
Open Access | Times Cited: 7
Altered postnatal developmental patterns of ultrasonic vocalizations in Dock4 knockout mice
Xiaoman Yang, Daji Guo, Keshen Li, et al.
Behavioural Brain Research (2021) Vol. 406, pp. 113232-113232
Closed Access | Times Cited: 9
Blockade of Serotonin 5-HT6 Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1
E. Doucet, Katarzyna Grychowska, Paweł Zajdel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10178-10178
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top